Prevalence and clinical usefulness of antiphospholipid and anticofactor antibodies in different Spanish preeclampsia subsets

Lupus

Volumn 21, Issue 3, 2012, Pages 257-263

  Ferrer Oliveras, R ^a   Llurba, E ^a   Cabero Roura, L ^a   Alijotas Reig, J ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

anti 2glycoprotein; anticardiolipin antibodies; antiphospholipid syndrome; lupus anticoagulant; pregnancy

Indexed keywords

ANNEXIN A5 ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHATIDYLSERINE ANTIBODY; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; TEACHING HOSPITAL; TERTIARY HEALTH CARE;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALS, TEACHING; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PRE-ECLAMPSIA; PREGNANCY; PREVALENCE; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 84856733763     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311425520     Document Type: Article

References (47)

1. Brown MA, Lindheimer MD, de Suite M, van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001 ; 20: 9-12
2. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynaecologists. Int J Gynaecol Obstet. 2002 ; 77: 67-75
3. Villar K, Say L, Gülmezoglu AM, et al Eclampsia and preeclampsia: a health problem for 2000 years. Crithley H MacLean AB Poston L Walker JJ, ed. Preeclampsia. London: RCOG Press ; 2003: 189-207.
4. Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy. 2003 ; 22: 203-212 (Pubitemid 37521372)
5. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005 ; 365: 785-799 (Pubitemid 40311367)
6. Moffett A, Hiby SE. How does the maternal immune system contribute to the development of preeclampsia?. Placenta. 2007 ; 28 (Suppl A). 51-56
7. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005 ; 330: 549-550
8. Hiby E, Walker JJ, O'Shaughnessy KM, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med. 2004 ; 200: 957-965 (Pubitemid 39431121)
9. Johnson MP, Fitzpatrick E, Dyer TD, et al. Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach. Mol Hum Reprod. 2007 ; 13: 61-67 (Pubitemid 44942725)
10. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989 ; 161: 1200-1204 (Pubitemid 20007682)
11. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003 ; 69: 1-7 (Pubitemid 36806800)
12. Zhou Y, McMaster M, Woo K, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002 ; 160: 1405-1423 (Pubitemid 34411644)
13. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004 ; 350: 672-683 (Pubitemid 38364626)
14. Levine RJ, Qian C, Maynard SE, Yu KF, Epstein FH, Karumanchi SA. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol. 2006 ; 194: 1034-1041
15. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
16. Salmon JE, de Groot PG. Pathogenic role of antiphospholipid antibodies. Lupus. 2008 ; 17: 405-411 (Pubitemid 351798717)
17. Salmon JE, Girardi G. Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation. J Reprod Immunol. 2008 ; 77: 51-56
18. Pierangeli SS, Chen PP, Raschi E, et al. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost. 2008 ; 34: 236-250
19. Giardi G. Guilty as charged: all available evidence implicates complement's role in fetal demise. Am J Reprod Immunol. 2008 ; 59: 183-192
20. Lynch AM, Gibbs RS, Murphy JR, et al. Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. Am J Obstet Gynecol. 2008 ; 199: 354-358
21. Heilmann L, von Tempelhoff GF, Pollow K. Antiphospholipid syndrome in obstetrics. Clin Appl Thromb Hemost. 2003 ; 9: 143-150 (Pubitemid 36665982)
22. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol. 1992 ; 80: 614-620
23. Tincani A, Bazzani C, Zingarelli S, Lojacono A. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment. Semin Thromb Hemost. 2008 ; 34: 267-273
24. Clark EA, Silver RM, Branch DW. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?. Curr Rheumatol Rep. 2007 ; 9: 219-225 (Pubitemid 46954780)
25. Audibert F, Friedman S, Frangie A, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP syndrome. Am J Obstet Gynecol. 1996 ; 175: 460-464
26. Soothill PW, Bobrow CS, Holmes R. Small for gestation age is not a diagnosis. Ultrasound Obstet Gynecol. 1999 ; 13: 225-228 (Pubitemid 29248327)
27. Loizou S, Mackworth-Young CG, Cofiner C, Walport MJ. Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis. Clin Exp Immuno. 1990 ; 80: 171-176 (Pubitemid 20147710)
28. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost. 1995 ; 74: 1185-1190
29. Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1995 ; 172: 642-648
30. Kaaja R. Predictors and risk factors of pre-eclampsia. Minerva Ginecol. 2008 ; 60: 421-429
31. Bodnar LM, Catov JM, Roberts JM. Racial/ethnic differences in the monthly variation of preeclampsia incidence. Am J Obstet Gynecol. 2007 ; 196: 324-325
32. Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan A. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension. 2008 ; 51: 1002-1009 (Pubitemid 351398985)
33. Engel SM, Janevic TM, Stein CR, Savitz DA. Maternal smoking, preeclampsia, and infant health outcomes in New York City, 1995-2003. Am J Epidemiol. 2009 ; 169: 33-40
34. Arnold J, Holmes Z, Pickering W, Farmer C, Regan L, Cohen H. Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. Br J Haematol. 2001 ; 113: 911-914 (Pubitemid 32634758)
35. Alijotas-Reig J, Ferrer-Oliveras R, Rodrigo-Anoro MJ, et al. Anti-annexin A5 antibodies in women with spontaneous pregnancy loss. Med Clin (Barc). 2010 ; 134: 433-438
36. Van Pampus MG, Dekker GA, Wolf H, et al. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol. 1999 ; 180: 1146-1150 (Pubitemid 29259008)
37. Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol. 1993 ; 100: 909-913 (Pubitemid 23308274)
38. Faden D, Tincani A, Tanzi P, et al. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta 2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol. 1997 ; 73: 37-42 (Pubitemid 27224458)
39. Allen JY, Tapia-Santiago C, Kutteh WH. Antiphospholipid antibodies in patients with preeclampsia. Am J Reprod Immunol. 1996 ; 36: 81-85 (Pubitemid 26318661)
40. Nodler J, Moolamalla SR, Ledger EM, Nuwayhid BS, Mulla ZD. Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset. BMC Pregnancy Childbirth. 2009 ; 16: 9-11
41. Yamada H, Atsumi T, Kobashi G, et al. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J Reprod Immunol. 2009 ; 79: 188-195
42. Scott RA. Anticardiolipin antibodies and preeclampsia. BJOG. 1987 ; 94: 604-605
43. Dreyfus M, Hedelin G, Kutnahorsky R, et al. Antiphospholipid antibodies and preeclampsia: a case-control study. Obstet Gynecol. 2001 ; 97: 29-34 (Pubitemid 32057151)
44. Lee RM, Brown MA, Branch DW, Ward K, Silver RM. Anticardiolipin and anti-beta 2-glycoprotein-I antibodies in preeclampsia. Obstet Gynecol. 2003 ; 102: 294-300 (Pubitemid 36937000)
45. Branch DW, Porter TF, Rittenhouse L, et al. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol. 2001 ; 184: 825-832
46. Obermoser G, Bitterlich W, Kunz F, Sepp NT. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Thromb Haemost. 2003 ; 90: 108-115
47. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med. 1985 ; 313: 1322-1326 (Pubitemid 16206021)